DiscoverThe Long Run with Luke TimmermanEp175: Andy Scharenberg on in vivo CAR-T cell therapies
Ep175: Andy Scharenberg on in vivo CAR-T cell therapies

Ep175: Andy Scharenberg on in vivo CAR-T cell therapies

Update: 2025-03-16
Share

Description

Andy Scharenberg, CEO of Seattle-based Umoja Biopharma, on developing in vivo CAR-T cell therapies.
Comments 
loading
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Ep175: Andy Scharenberg on in vivo CAR-T cell therapies

Ep175: Andy Scharenberg on in vivo CAR-T cell therapies

Timmerman Report